These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16888673)

  • 1. [Hepatocarcinogenesis in human liver].
    Nagy P; László V; Schaff Z
    Magy Onkol; 2006; 50(2):107-13. PubMed ID: 16888673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological changes of early human hepatocarcinogenesis.
    Hytiroglou P
    Semin Liver Dis; 2004 Feb; 24(1):65-75. PubMed ID: 15085487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on precursor and early lesions of hepatocellular carcinomas.
    Park YN
    Arch Pathol Lab Med; 2011 Jun; 135(6):704-15. PubMed ID: 21631263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity at D8S262: an early genetic event of hepatocarcinogenesis.
    Zhu Q; Gong L; Liu X; Wang J; Ren P; Zhang W; Yao L; Han X; Zhu S; Lan M; Li Y; Zhang W
    Diagn Pathol; 2015 Jun; 10():70. PubMed ID: 26076954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latest developments in precancerous lesions of hepatocellular carcinoma.
    Niu ZS; Niu XJ; Wang WH; Zhao J
    World J Gastroenterol; 2016 Mar; 22(12):3305-14. PubMed ID: 27022212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness.
    Tsujikawa H; Masugi Y; Yamazaki K; Itano O; Kitagawa Y; Sakamoto M
    Hum Pathol; 2016 Apr; 50():24-33. PubMed ID: 26997435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preneoplastic lesions in human hepatocarcinogenesis.
    Libbrecht L; Desmet V; Roskams T
    Liver Int; 2005 Feb; 25(1):16-27. PubMed ID: 15698394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal morphological changes and immunophenotypic features of precancerous lesions and hepatocellular carcinoma.
    Chen D; Li Z; Zhu W; Cheng Q; Song Q; Qian L; Zhu JY
    J Clin Pathol; 2019 Apr; 72(4):295-303. PubMed ID: 30610005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma.
    Chuma M; Sakamoto M; Yamazaki K; Ohta T; Ohki M; Asaka M; Hirohashi S
    Hepatology; 2003 Jan; 37(1):198-207. PubMed ID: 12500205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic precancerous lesions and small hepatocellular carcinoma.
    Hytiroglou P; Park YN; Krinsky G; Theise ND
    Gastroenterol Clin North Am; 2007 Dec; 36(4):867-87, vii. PubMed ID: 17996795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
    Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
    J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity.
    Kudo M
    Intervirology; 2004; 47(3-5):227-37. PubMed ID: 15383732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
    Choi YL; Park SH; Jang JJ; Park CK
    J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of AT-rich interactive domain 1A in hepatocellular carcinoma.
    Abe H; Hayashi A; Kunita A; Sakamoto Y; Hasegawa K; Shibahara J; Kokudo N; Fukayama M
    Int J Clin Exp Pathol; 2015; 8(3):2763-70. PubMed ID: 26045782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens.
    Choi WT; Ramachandran R; Kakar S
    Hum Pathol; 2017 May; 63():1-13. PubMed ID: 28087475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia.
    Cohen C; DeRose PB
    Mod Pathol; 1994 Jun; 7(5):536-9. PubMed ID: 7937718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma.
    Fujiwara Y; Shimada M; Takenaka K; Kajiyama K; Shirabe K; Sugimachi K
    Hepatogastroenterology; 2002; 49(43):213-7. PubMed ID: 11941958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].
    Pozharisskiĭ KM; Granov DA; Ten VP; Kubaĭbergenova AG; Leenman EE; Rasskazov AI
    Vopr Onkol; 2008; 54(4):417-33. PubMed ID: 18942395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.
    Qin LX; Tang ZY
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):497-513. PubMed ID: 15205947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver.
    Osada T; Sakamoto M; Nishibori H; Iwaya K; Matsuno Y; Muto T; Hirohashi S
    J Hepatol; 1997 Jun; 26(6):1266-73. PubMed ID: 9210613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.